Abstract
A randomized study on the effect of the following four treatment regimens on Plasmodium falciparum parasitaemia was carried out on 200 asymptomatic schoolchildren in Maputo, Mozambique: chloroquine (25 mg/kg body weight), amodiaquine (25 mg/kg), sulfadoxine—pyrimethamine (25 mg/kg and 1.25 mg/kg), or amodiaquine (25 mg/kg) + sulfadoxine—pyrimethamine (25 mg/kg and 1.25 mg/kg) administered on the third day of the study. The results of in vivo tests indicated that 94% of the infections were resistant to chloroquine, 76% to amodiaquine, and 16% to sulfadoxine—pyrimethamine. The cure rate with amodiaquine + sulfadoxine—pyrimethamine was 100%, which was not significantly different from that with sulfadoxine—pyrimethamine alone; the latter regimen was the most rapidly acting of the treatments studied. It is concluded that amodiaquine is not an appropriate substitute for chloroquine, but that the effect of the combination amodiaquine + sulfadoxine—pyrimethamine may be superior to that of sulfadoxine—pyrimethamine alone, although this requires further study.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Churchill F. C., Patchen L. C., Campbell C. C., Schwartz I. K., Nguyen-Dinh P., Dickinson C. M. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci. 1985 Jan 7;36(1):53–62. doi: 10.1016/0024-3205(85)90285-1. [DOI] [PubMed] [Google Scholar]
- Curtis C. F., Otoo L. N. A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Trans R Soc Trop Med Hyg. 1986;80(6):889–892. doi: 10.1016/0035-9203(86)90248-8. [DOI] [PubMed] [Google Scholar]
- Schapira A., Bygbjerg I. C., Jepsen S., Flachs H., Bentzon M. W. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results. Am J Trop Med Hyg. 1986 Mar;35(2):239–245. doi: 10.4269/ajtmh.1986.35.239. [DOI] [PubMed] [Google Scholar]
- Schapira A. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates. Trans R Soc Trop Med Hyg. 1984;78(3):359–362. doi: 10.1016/0035-9203(84)90122-6. [DOI] [PubMed] [Google Scholar]
- Smalley M. E., Brown J. In vitro demonstration of pyrimethamine resistance of "wild" Plasmodium falciparum in The Gambia. Trans R Soc Trop Med Hyg. 1982;76(3):324–328. doi: 10.1016/0035-9203(82)90181-x. [DOI] [PubMed] [Google Scholar]
- Spencer H. C., Watkins W. M., Sixsmith D. G., Koech D. K., Chulay J. D. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya. Bull World Health Organ. 1984;62(4):615–621. [PMC free article] [PubMed] [Google Scholar]
- Watkins W. M., Sixsmith D. G., Spencer H. C., Boriga D. A., Kariuki D. M., Kipingor T., Koech D. K. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet. 1984 Feb 18;1(8373):357–359. doi: 10.1016/s0140-6736(84)90410-0. [DOI] [PubMed] [Google Scholar]